-release channels with each subunit containing a binding site for IP 3 in the amino terminus. We provide evidence that four IP 3 molecules are required to activate the channel under diverse conditions. Comparing the concentrationresponse relationship for binding and Ca 2+ release suggested that IP 3 Rs are maximally occupied by IP 3 before substantial Ca 2+ release occurs. We showed that ligand binding-deficient subunits acted in a dominant-negative manner when coexpressed with wild-type monomers in the chicken immune cell line DT40-3KO, which lacks all three genes encoding IP 3 R subunits, and confirmed the same effect in an IP 3 R-null human cell line (HEK-3KO) generated by CRISPR/Cas9 technology. Using dimeric and tetrameric concatenated IP 3 Rs with increasing numbers of binding-deficient subunits, we addressed the obligate ligand stoichiometry. The concatenated IP 3 Rs with four ligand-binding sites exhibited Ca 2+ release and electrophysiological properties of native IP 3 Rs. However, IP 3 failed to activate IP 3 Rs assembled from concatenated dimers consisting of one binding-competent and one binding-deficient mutant subunit. Similarly, IP 3 Rs containing two monomers of IP 3 R2 short , an IP 3 binding-deficient splice variant, were nonfunctional. Concatenated tetramers containing only three binding-competent ligandbinding sites were nonfunctional under a wide range of activating conditions. These data provide definitive evidence that IP 3 -induced Ca 2+ release only occurs when each IP 3 R monomer within the tetramer is occupied by IP 3 , thereby ensuring fidelity of Ca 2+ release.
INTRODUCTION
The modulation of intracellular calcium concentration [Ca 2+ ] i is a signal used by all living organisms to control many cellular processes, including gene transcription, regulated secretion, proliferation, muscle contraction, fertilization, and apoptosis (1) . Inositol 1,4,5-trisphosphate (IP 3 ) receptors (IP 3 Rs) are ligand-gated calcium channels present in most eukaryotic species (1-3). There are three homologous isoforms ubiquitously distributed in mammalian tissues (denoted as IP 3 R1, IP 3 R2, and IP 3 R3) (4) . The individual channel is assembled with a tetrameric architecture consisting of homo-or heteromeric subunits and is localized in the membranes of intracellular calcium stores, such as the endoplasmic reticulum and sarcoplasmic reticulum (3, 5) . Each IP 3 R subunit consists of~2700 amino acids and three functional domains: the N-terminal IP 3 -binding domain, an intervening modulatory domain, and the C-terminal channel domain containing six transmembrane helices and the Ca 2+ -permeable pore (5, 6) . All known regulatory sites, including phosphorylation sites, nucleotide binding sites, and interaction motifs with protein binding partners are present in each monomer (3, 5, 7) . Accordingly, each monomer contributes a ligand-binding site to the tetrameric channel.
Previous studies suggest that IP 3 binding triggers inter-or intramolecular conformational changes between subunits involving interactions between the N and C termini that ultimately culminate in channel opening and Ca 2+ release (8) (9) (10) (11) . However, fundamental questions regarding the molecular basis of channel gating remain (12, 13) . For example, the number of IP 3 molecules required to open the tetrameric IP 3 R channel is not established; indeed, the stoichiometry necessary for any regulatory input is not known. Understanding the stoichiometry of IP 3 R regulation is especially important because IP 3 R dysfunction as a result of mutations in the protein has been implicated in human pathologies, such as anhidrosis (an inability to perspire) and spinocerebellar ataxia (14) (15) (16) , and IP 3 Rassociated diseases occur in the heterozygous condition in which the IP 3 R channel is likely formed from various combinations of normal and mutant monomers (16, 17) .
Although IP 3 binding to IP 3 R is not generally reported to be highly cooperative (18, 19) , some studies have reported Ca 2+ release to be highly cooperative in permeabilized cell systems (20, 21) . This cooperative relationship could be a consequence of Ca 2+ facilitating further release by acting as a coagonist; however, the cooperativity has been observed in experiments in which intracellular Ca 2+ is buffered (20, 22) . One explanation for the cooperative Ca 2+ release has been that at least three ligandbinding events are required for channel opening (20, 23) . Contrary to this idea, transiently expressed IP 3 R channels engineered with only two intact binding sites are reported to be activated by IP 3 (10) . Further, structural analysis by cryoelectron microscopy (cryo-EM) suggests that, as a result of interactions between the C terminus of one subunit and the N termini of neighboring subunits, IP 3 binding to one subunit induces conformational changes in two adjacent subunits, and thus, this model implies the requirement for binding of less than four molecules of IP 3 for channel gating (11) . Nevertheless, a comprehensive molecular methodology has never been attempted to address how many IP 3 molecules are necessary to activate IP 3 R channels. Here, we engineered concatenated IP 3 R, in which progressive numbers of IP 3 -binding sites were disrupted by either mutation or incorporation of naturally occurring binding-deficient mutants. Furthermore, we expressed these concatenated receptors in cells lacking IP 3 Rs, thereby avoiding issues of incorporation of endogenous subunits into the channel. With these concatenated receptors, we systematically monitored IP 3 R activity and addressed the stoichiometry of IP 3 molecules required for optimum channel function. Our data establish that IP 3 -induced Ca 2+ signals are only initiated after occupation of IP 3 R by four IP 3 molecules.
RESULTS
The relationship between IP 3 binding and IP 3 R activation is complex
The DT40-3KO cell line is a chicken B-lymphoid cell type that has been genetically modified to be deficient in all subunits of the IP 3 R (24, 25) . Thus, these cells provide a system for analyzing IP 3 Rs with controlled subunit composition. We investigated the relationship between IP 3 binding and IP 3 (20) . Thus, these data suggest that multiple subunits must be occupied to initiate Ca 2+ release. Next, we tested whether incorporating IP 3 binding-defective subunit(s) into the tetrameric assembly impaired IP 3 R channel function. Positively charged residues scattered in the N terminus of IP 3 R subunits mediate IP 3 binding (26) . These early studies, which defined the IP 3 -binding domain, replaced key arginine and lysine residues absolutely required for IP 3 binding with glutamine. The rationale being that lysine, arginine, and glutamine are amphipathic and have similar side-chain conformational entropy, and thus, the mutation, while negating the positive charge, is predicted to be less disruptive to the structural and functional integrity of the receptor (26) . In mammalian IP 3 R family members, there are 10 conserved basic residues that are essential for binding, and 3 of which are considered critical for specific binding (R   265   , K   508 , and R
511
; residue numbering based on Rat IP 3 R1) (26) . Although initial studies using IP 3 R1 with a single R265Q mutation reported that this mutant does not bind IP 3 and thus is not activated by IP 3 (10, 26) , a subsequent study showed that this construct retains IP 3 binding capacity (27) .
To resolve this discrepancy, we generated two different IP 3 R1 mutants, IP 3 R1.R265Q (designated as R1 Q ) and IP 3 R1.R265/K508/R511Q (designated as R1 QQQ ), and stably transfected plasmids encoding these into IP 3 R-null, DT40-3KO cells. When compared to wild-type IP 3 R1 (designated as R1), R1 QQQ retained no binding activity, whereas R1 Q retained low but detectable binding (~10%) (Fig. 2A) . In permeabilized cell unidirectional Ca
2+
-release assays, IP 3 evoked robust Ca 2+ release from cells expressing R1, but IP 3 failed to release Ca 2+ in nontransfected DT40-3KO cells or cells stably expressing R1 QQQ (Fig. 2B) . However, cells expressing R1 Q produced a small but measurable Ca 2+ signal in response to exogenous IP 3 , suggesting that the residual binding capacity of this mutant supported limited channel activation under these assay conditions.
Using the stably transfected DT40-3KO, we investigated the ability of these IP 3 R1 constructs to respond to IP 3 -generating stimuli in intact cells. We challenged cells with the Ga q -coupled G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor (GPCR) agonists, endothelin and trypsin. We also stimulated the B cell receptor (BCR), a tyrosine kinase receptor, by crosslinking with an antibody recognizing IgM. All three IP 3 -producing stimuli failed to trigger Ca 2+ release in DT40-3KO and cells expressing R1 Q or R1 QQQ , whereas DT40-3KO cells expressing R1 showed robust responses to all three stimuli (Fig. 2, C and D, and fig. S1, A and B). The contradictory behavior of R1 Q in the two assay systems is likely due to the different experimental conditions. In particular, the permeabilized cell assay exposes IP 3 R to uniform maximum concentrations of IP 3 and adenosine 5′-triphosphate (ATP), whereas the intact cell assay relies on endogenously produced IP 3 downstream of surface receptor signaling that likely results in less intense stimulation. These data clearly illustrated that the use of the single point mutation (R265Q) is inadequate for assessing ligand stoichiometry. Therefore, we used R1 QQQ for the subsequent experiments.
Mutagenesis in the ligand-binding domain is unlikely to result in a global structural rearrangement of IP 3 R A concern associated with functional analysis of mutated proteins is that any substitution may interfere with protein folding, resulting in unwanted, allosteric effects beyond the intended targeted disruption. To investigate whether the introduction of glutamine residues in R1 QQQ markedly disrupted the overall structural integrity of IP 3 R1, we analyzed the available IP 3 R structures. A cryo-EM study at 4.7 Å shows the fulllength IP 3 R (Fig. 3A) , but the local resolution in the IP 3 -binding site is not sufficient to reveal individual side chains (11) . Therefore, we used a crystal structure of the N-terminal region, captured in the absence of IP 3 (9) . The crystal structure contains two IP 3 R molecules in the asymmetric unit, which show identical folds and relative domain orientations upon superposition. Each of the three mutated residues (R 265 , K 508 , and R 511 ) is surface-accessible and is not involved in domaindomain interactions (Fig. 3, B and C) . To verify that the mutations are sterically allowed, we generated a homology model of the ligand-binding domain using Modeller, which satisfied spatial restraints (28) . Although a high-resolution structure of the R1 QQQ mutant would be required to unequivocally rule out any major conformational changes, our homology model predicted that the glutamine side chains did not produce substantial rearrangements of neighboring residues. Furthermore, the side chains of R 265 and K 508 make no significant interactions with other residues, and the few hydrogen bonds (Fig. 3C ) are only observed in one of two molecules in the asymmetric unit. R 511 makes hydrogen bonds with two neighboring residues, observed in both molecules of the asymmetric unit (Fig. 3C) . However, because these residues are within the same domain, we predict that it is unlikely that disruption would result in longrange allosteric effects (Fig. 3D) 3 R complexes in various combinations. To establish that transiently transfected R1 oligomerized with stably expressed R1 proteins in the DT40-3KO cell system, we performed coimmunoprecipitation experiments, which confirmed that transiently expressed cherryR1 associated with stably expressed FLAG-tagged IP 3 R1 (Fig. 4A, inset) . Although we cannot formally exclude the possibility of intermolecular interactions between adjacent homomeric populations of IP 3 R constructs, these data suggested that tetrameric IP 3 R complexes can be assembled from transiently and stably coexpressed IP 3 R subunits in DT40-3KO cells.
DT40-3KO transfected with cherryR1 supported robust Ca 2+ release in response to trypsin, whereas stimulation of R1 QQQ cells transfected with cherryR1 resulted in weak Ca 2+ release ( Fig. 4A and pooled data in Fig. 4B ). These data indicated that, although transiently transfected cherryR1 assembled to form functional channels in DT40-3KO, the coexpression and incorporation of ligand binding-defective subunit (s) inhibited the formation of competent channels. Together, these findings suggested that incorporating a mutant subunit(s) impairs the tetrameric channel function, which supports the hypothesis that an IP 3 R with less than four intact ligand-binding sites does not function as an IP 3 -gated Ca 2+ channel. Although DT40-3KO cells are a useful expression system, there are caveats associated with this cell line, such as their relatively low transfection efficiency and their nonmammalian origin. Therefore, we sought to confirm our findings in a mammalian cell type. Human embryonic kidney (HEK) 293 cells are widely used, easily maintained, and readily transfected, but all three IP 3 R subtypes are present in these cells ( fig. S2A ). To generate IP 3 R-null HEK293 cells, we used CRISPR/Cas9 gene editing to simultaneously disrupt all three IP 3 R-encoding genes (29) . Genotyping, Western blot analyses, and single-cell imaging confirmed the disruption of IP 3 Rencoding genes and the absence of functional IP 3 Rs ( Fig. 2A, fig. S2B , and table S1).
We assessed the effect of wild-type IP 3 R1 and binding-defective subunit (R1 QQQ ) on channel function in these IP 3 R-deficient HEK293 cells (designated as HEK-3KO). The amount of cherryR1 was similar under both conditions (Fig. 4C, inset ). As expected, cherryR1 alone expressed mediated robust Ca 2+ release in response to trypsin ( Fig. 4C and pooled data in Fig. 4D ). Coexpression of R1 QQQ with cherryR1 significantly attenuated the trypsin-induced Ca 2+ response. Cotransfection would be anticipated to result in a binomial distribution of heterotetrameric assemblies of all combination of R1 and R1 QQQ (30) . The degree of inhibition of Ca 2+ release appears inconsistent with a minority population of homomeric R1 QQQ and indicates that the mutant subunit likely exhibits dominantnegative effects when present in the complex with some wild-type subunits.
IP 3 R1 tetramers with two IP 3 binding-deficient subunits lack activity
Our results thus far indicated that a tetrameric channel with less than four intact binding sites is not an IP 3 -gated Ca 2+ channel. However, in these experimental paradigms, it is not possible to accurately define the subunit composition of each assembled channel. To address precisely how many binding sites are required for channel activation, we generated concatenated channels with predefined subunit composition. Constructs encoding dimeric concatenated IP 3 R (for cartoon, see Fig. 5A ) generate proteins that dimerize to form authentic IP 3 -gated tetrameric channels ( Fig. 5B) (31, 32) . To determine whether IP 3 R channels with two ligand binding-deficient subunits are functional, we engineered concatenated IP 3 R constructs in which two IP 3 R1 molecules are linked tail-to-head. We constructed two dimeric concatenated receptors with different configurations containing wildtype subunits and IP 3 binding-deficient subunits, designated as R1R1 QQQ and R1 QQQ R1, and stably expressed them in DT40-3KO (Fig. 6A ). Permeabilized cell assays demonstrated that cells expressing R1R1 QQQ did not produce any Ca 2+ release in response to application of IP 3 , suggesting that channels containing two mutant subunits were not functional ( . Together, these findings showed that binding of two IP 3 molecules is not sufficient to activate tetrameric IP 3 R channels. Notably, we observed Ca 2+ -release activity in both the permeabilized cell assay and by single-cell imaging in cells expressing tetrameric channels assembled from R1 Q R1 or R1R1 Q dimers ( fig. S4, A to D) . These channels consist of two wild-type IP 3 R subunits and two R1 Q subunits. The results are consistent with the residual binding activity of monomeric R1 Q subunits ( Fig. 2A) .
A functional IP 3 R1 channel can be generated as one concatenated molecule
To precisely control the subunit composition of the receptor without the complicating factor of oligomerization, we generated IP 3 R from a single concatenated polypeptide with a 14-amino acid linker between the subunits and expressed this protein in DT40-3KO cells. We confirmed by Western blotting that the wild-type version of this IP 3 R1 construct (R1R1R1R1) could be stably expressed in DT40-3KO cells (Fig. 7A, left) . Cells expressing R1R1R1R1 exhibited robust IP 3 -induced Ca 2+ release in the permeabilized cell assay (Fig. 7B ) and agonist-induced Ca 2+ signals in intact cells (Fig. 7, C and D, and fig. S5 , A and B). Pivotal to interpretation of these data is to confirm that the concatenated tetrameric channel behaves in an identical fashion to IP 3 R assembled from wild-type subunits. To confirm that the concatenated channel generated from a single polypeptide chain had the same electrophysiological properties as IP 3 R assembled from wild-type monomer subunits, we performed extensive electrophysiological analyses of single-channel properties with the "onnucleus" configuration of patch clamp. ATP and Ca 2+ function as coagonists with IP 3 of the IP 3 R and enhance the responsiveness of the channel IP 3 (3, 33) . Single-channel recordings of R1R1R1R1 showed that the channel was activated by IP 3 and that the response to IP 3 was enhanced by either increasing the concentration of ATP (Fig.  7E , left) or Ca 2+ (Fig. 7E, right) . Indeed, the activity of channels produced from monomers, concatenated dimers, or the single polypeptide concatenated tetramer was indistinguishable in terms of currentvoltage relationship ( fig. S6, A to D (Fig. 7A, right) . Cells expressing this construct were unresponsive to application of IP 3 in the permeabilized cell assay (Fig. 7B ) and did not display any Ca 2+ signal in intact cells when stimulated with trypsin ( Fig. 7C and pooled data in Fig. 7D ) or endothelin ( fig. S12A ) or in response to BCR stimulation ( fig. S12B ). In single-channel electrophysiological studies, varying Ca 2+ and ATP with IP 3 concentrations as high as 100 mM never elicited any IP 3 R channel activity (Fig. 7F) . In total, these data suggested that a fundamental property of the IP 3 R is the requirement for each monomer to bind IP 3 to achieve channel activation.
IP 3 R2 containing two binding-deficient IP 3 R2 (short) splice variant subunits lacks activity
The necessity for IP 3 binding to each subunit of the IP 3 R tetramer may also have physiological consequences beyond the fundamental biophysical requirement to initiate Ca 2+ release. A widely distributed splice variant of mammalian IP 3 R2 (R2 short ) does not bind IP 3 despite having an intact ligandbinding domain (18) . This splice variant lacks amino acids 176 to 208. These amino acids are in the region termed the "suppressor domain," which is a major modulator of IP 3 -binding affinity (19, 26) , and channels formed by this variant are nonfunctional (18 (Fig.  8B ). However, a channel containing two subunits of R2 short or R2 QQ was not functional in response to trypsin activation ( Fig. 8C and pooled data in Fig. 8D ). These results indicated that this widely distributed variant could incorporate into tetrameric receptors and that the result would be to dampen or even eliminate intracellular Ca 2+ signals produced by IP 3 -stimulated release from the intracellular stores. In summary, the experiments presented here support the conclusion that four binding-competent subunits are required for IP 3 -mediated channel activation and demonstrate the general utility of concatenated proteins to illuminate IP 3 R biology.
DISCUSSION
A question fundamental to understanding the activation of IP 3 R is how the IP 3 -binding event in the N terminus of the IP 3 R subunit is transmitted to the complementary DNA (cDNA) construct flanked by the two arms of the linear vector, pJAZZ mamm. The "head" subunit (cDNA coding for rat IP 3 R1 QQQ ) was modified so that it contains an Nco I site just before the start codon. The stop codon was deleted and a nucleotide sequence coding for a sevenamino acid linker was added after the IP 3 R1 coding sequence followed by an Age I site. The "tail" subunit (cDNA coding for rat IP 3 R1) was modified so that it contains an Age I site followed by a nucleotide sequence coding for a seven-amino acid linker inserted before the start codon, and a blunt end restriction site was inserted after the stop codon. The resultant construct encodes one open reading frame consisting of two IP 3 R subunits connected with a 14-amino acid linker. CT, C terminus; NT, N terminus. (B) A scheme showing how dimeric R1R1 molecules assemble to form a tetrameric channel. channel pore localized in the distant C terminus (8, 10, 13, 34) . Multiple intra-and intersubunit interactions revealed by biochemical and structural studies, including a current model generated from a cryo-EM structure of the entire IP 3 R at 4.7 Å resolution (8) (9) (10) (11) 35) , are likely critical to coupling IP 3 binding to channel opening. Central to understanding how the interactions between various domains gate the channel is determining the obligatory stoichiometry of IP 3 binding necessary for channel activation. Here, we provide several lines of evidence from assaying IP 3 R channel activity that indicate that IP 3 R channels must bind four IP 3 molecules to initiate activation and Ca 2+ release. First, an analysis of the relationship between IP 3 binding and unidirectional Ca 2+ flux is consistent with the idea that IP 3 R1 has to be nearly fully occupied before Ca 2+ release is activated. Because Ca 2+ release is not an "all-or-nothing" event, these data can be explained if the graded response to IP 3 is a consequence of mass action increasing the probability that all four monomers are concurrently IP 3 -bound. Second, coexpression of wild-type and ligand-binding defective subunits in both HEK-3KO and DT40-3KO cells significantly attenuated the formation of functional channels as evidenced by an apparent dominantnegative effect of ligand binding-deficient subunits. Clearly, the most definitive approach implemented in this study is the use of concatenated constructs whereby a single polypeptide channel of any predefined composition can be fashioned and expressed in isolation.
Previously, we characterized the biochemical and biophysical properties of the IP 3 Rs assembled from dimers of concatenated pairs of subunits expressed as a single polypeptide (31, 32) .
Here, we extended this approach to produce channels of defined composition from all four subunits expressed as a single concatenated polypeptide. No oligomerization of individual subunits is necessary to form functional channels with this construct. These channels assembled from concatenated dimers (31) or a single concatenated polypeptide of all four subunits had the same properties as wild-type channels in terms of IP 3 binding, Ca 2+ release, the amplitude and frequency of evoked Ca 2+ signals, and the increase in IP 3 sensitivity resulting from ATP and Ca
2+
. Further validation presented here showed that the single-channel conductance and open probability under various conditions are like those of channels assembled from monomeric subunits. Moreover, channel open and closed times, characteristics of channel gating, and the biophysical fingerprints of IP 3 R were identical comparing monomeric, concatenated dimeric, or concatenated tetrameric IP 3 R (as summarized in Table 1 and table S2 ). These data indicated that linking the IP 3 R subunits does not constrain the normal gating of the channel and established that the concatenation of subunits is a valid technique to interrogate IP 3 R function. Indeed, the cryo-EM structure of IP 3 R1 shows a close juxtaposition of the N and C termini of the tetrameric channel, which may explain how the four subunits of this extremely large tetrameric complex can be linked without compromising channel structure and, thus, activity (11) .
Taking advantage of this approach, we systematically demonstrated that channels with fewer than four competent ligand-binding sites do not form IP 3 R capable of opening and initiating Ca 2+ release. Initially, we examined the IP 3 -induced activity of concatenated dimeric IP 3 R1 with one wild-type and one ligand binding-deficient subunit. This construct is expected to form channels with two intact binding sites. The results of three complementary experimental approaches to monitor channel activity indicated that two IP 3 -binding events are not sufficient for channel activation. This notion is, however, not consistent with a previous report that heterotetrameric channels assembled from R1 Q and binding-competent subunits were partially functional, leading the authors to conclude that less than full occupancy by IP 3 was sufficient to gate IP 3 R (10). Although differing experimental systems and measurements of activity were used in this study, an interpretation from our data is that Ca 2+ release observed in the previous study may be a consequence of the substantial IP 3 binding and Ca
-release activity retained by the R1 Q subunit and thus does not necessarily provide definitive evidence of the stoichiometry of IP 3 binding. Notwithstanding this apparent discrepancy, the absence of any activity in a concatenated single polypeptide channel with three intact binding sites is again consistent with the concept that all four subunits must be bound to the ligand to initiate Ca 2+ release. IP 3 R activation is a complex process and involves binding of Ca
, IP 3 , ATP, and perhaps many other factors, including protein association or dissociation, redox regulation, and phosphorylation status (3, 7, 36) . IP 3 is obligate for channel opening and Ca 2+ is also required for optimal channel activation, although the exact mechanism by which these two coagonists interact is not well established (3, 12, 26) . Current proposals suggest that after IP 3 binding, Ca
-regulatory sites can be engaged to enhance IP 3 R open probability (3, 22) . Our data are important in understanding the activation of IP 3 R involved in the initial Ca 2+ release at "trigger" zones (37). The initial IP 3 -induced Ca 2+ -release event occurs before local Ca 2+ concentrations at the IP 3 R have increased; thus, the intracellular Ca 2+ concentration near the IP 3 R would likely be less than the threshold needed to regulate IP 3 R activity. Our single-channel data obtained with a Ca 2+ concentration mimicking cellular resting levels, together with the intact-cell intracellular Ca 2+ concentration measurements in cells that were stimulated with agonists that increase IP 3 , revealed that full IP 3 engagement of the IP 3 R is necessary for the initial activation. These data are, therefore, consistent with the idea that upon stimulation, there is no absolute requirement for Ca 2+ concentrations to increase above the resting level to initially open the IP 3 R. Nevertheless, after the initial activation, neighboring IP 3 Rs will experience an increase in local Ca 2+ concentration; therefore, it is possible that the IP 3 -binding requirement is altered under these conditions. However, we found that in permeabilized cell assays and single-channel recordings, constructs with fewer than four intact binding sites were refractory to opening over a wide range of activating IP 3 , Ca 2+ , and ATP concentrations. Although many factors may affect the kinetics of IP 3 R channel opening after binding of four IP 3 molecules, we conclude that each of the four subunits must bind IP 3 for the channel to open. IP 3 R activity can be modulated by a variety of factors not addressed in the current studies, including by binding partners and redox modification (7, 22, 36, 38, 39) . In general, these events occur by allosteric regulation of the functional affinity for IP 3 and not by altering IP 3 binding directly. Thus, although our findings clearly show that all four subunits must be bound to IP 3 to trigger channel activity in the conditions tested, it remains possible that the stoichiometry of IP 3 activation of IP 3 R may be altered under particular metabolic conditions or in the presence of binding partners.
Why has IP 3 R evolved to require that each monomer is bound to IP 3 before activation? Intracellular Ca 2+ is essential for almost all cellular processes but, paradoxically, has detrimental consequences if not fine-tuned to meet the cell's physiological needs. Thus, eukaryotic cells have evolved very intricate Ca 2+ -signaling cascades with multiple layers of checks and balances to maintain strict control over intracellular Ca 2+ concentrations. The requirement for maximum ligand occupancy for channel activation may ensure against unwarranted and potentially deleterious increases in intracellular Ca 2+ (20) . Finally, the experimental approach used in this study can be extended to address many unanswered questions pertaining to IP 3 R biology, including the investigation of other ligand or binding factor stoichiometries, such as ATP, Ca 2+ , or calmodulin (7, 22) . Similarly, an increasing number of IP 3 R mutations have been identified in human diseases, many of which clinically manifest in heterozygous patients (14) (15) (16) (17) . We predict that the use of concatenated IP 3 R with the defined expression of monomers will be the method of choice to examine the pathophysiological roles of IP 3 R channels containing various combinations of wild-type and mutant subunits.
MATERIALS AND METHODS

Reagents
All reagents used for SDS-polyacrylamide gel electrophoresis (SDS-PAGE) were from Bio-Rad. DNA T4 ligase and restriction enzymes were purchased from New England Biolabs. Dulbecco's modified Eagle's medium (4.5g/liter D-glucose), RPMI 1640 media, G418 sulfate, penicillin/ streptomycin, chicken serum, and b-mercaptoethanol were obtained from Life Technologies. Fetal bovine serum was purchased from Gemini. Protein A/G agarose beads were purchased from Santa Cruz Biotechnology. Rabbit antibodies recognizing IP 3 R1 (CT1) raised against the 19 Cterminal amino acids of rat IP 3 R1 and rabbit antibodies recognizing IP 3 R2 raised against amino acids 320 to 338 in mouse IP 3 R2 were generated by Pocono Rabbit Farm and Laboratories (31, 41) . Mouse monoclonal antibody against residues 22 to 230 of human IP 3 R3 was from BD Transduction Laboratories. DyLight 800CW secondary antibodies were from Thermo Scientific. Fura2-AM was from TEFLabs. All other chemicals were obtained from Sigma unless otherwise indicated.
Plasmid construction
All constructs used in this study were based on rat IP 3 R1 or mouse IP 3 R2 cloned in pcDNA3.1. DNA modifications were made after QuikChange mutagenesis as described before (31) . All polymerase chain reaction steps were carried out using Pfu Ultra II Hotstart 2× Master Mix (Agilent). Primers used in this study were synthesized by Integrated DNA Technologies and are listed in table S3. To generate IP 3 R1-R265Q, F1 and R1 primers were used. To introduce K508Q and R511Q mutations into IP 3 R1, F2 and R2 primers were used. To make mCherry-IP 3 R1 fusion protein, an Nhe I site was engineered immediately after the start codon in IP 3 R1 using F3 and R3 primers. To subclone mCherry coding sequence from pmCherry-C1 (Clontech), an Nhe I site was introduced at the end of coding sequence of mCherry using primer pair F4 and R4. The modified pmCherry-C1 plasmid was digested with Nhe I, and the Nhe I-Nhe I fragment flanking the mCherry coding region was inserted into the Nhe I site engineered before IP 3 R1 coding sequence. To add a FLAG tag to the C terminus of IP 3 R1, F5 and R5 were used. To mutate the ligand-binding domain IP 3 R2, F6 and R6 were used to introduce R568Q and K569Q mutations. Finally, F7 and R7 primer pair was used to make R2 short . The coding sequences and desired DNA modifications were confirmed by sequencing. Concatenated IP 3 R subunits were created as described before (31, 32) . Briefly, to make a concatenated R1R1 or R2R2 dimer, the corresponding IP 3 R cDNAs in pcDNA3.1(+) vector were modified to introduce unique restriction sites and extra nucleotides encoding the seven-amino acid linker (QLNQLQT), and two cDNAs coding for IP 3 R subunits were then ligated tail-to-head between the two arms of pJAZZ mamm linear vector based on coliphage N15 (Lucigen). The resulting construct encodes two IP 3 R subunits conjugated with a 14-amino acid linker. Similarly, concatenated tetrameric IP 3 R1 was made by linking four subunits to form one reading frame encoding four IP 3 R subunits with 14-amino acid linkers separating one subunit from the next. The coding sequences and desired DNA modifications were confirmed by sequencing.
Cell culture and transfection DT40-3KO cell line and HEK293 cells were maintained accordingly as described before (2, 31) . DT40-3KO cells were transiently transfected as follows: 5 million cells were pelleted by centrifugation and washed once with phosphate-buffered saline (pH 7.3) and then electroporated with 5 mg of plasmid DNA using Amaxa Cell Nucleofector Kit T (Lonza Laboratories). Cells were supplied with fresh complete RPMI medium [RPMI 1640 medium supplemented with 1% chicken serum, 10% fetal bovine serum, penicillin (100 U/ml), streptomycin (100 mg/ml)] and allowed to recover for 24 hours and then used for experiments. For the generation of stable cell lines, 24 hours after transfection, cells were plated in medium containing G418 (2 mg/ml) in five 96-well plates. After 10 to 14 days, Western blot analyses were used to screen G418-resistant clones for expression of the desired constructs. For HEK293 cell transfection, cells were transfected with cDNA constructs using Lipofectamine 2000 following the manufacturer's protocol. Cells were used for experiment 24 to 48 hours after transfection. Cell lysates, SDS-PAGE, and coimmunoprecipitation were carried out as described before (40) .
CRISPR-mediated disruption of human IP 3 R complements in HEK293 cells
Single-guide RNA (sgRNA) target sites in human ITPR1, ITPR2, and ITPR3 loci were identified using CRISPR.mit.edu (29) . Oligonucleotides corresponding to these sgRNAs, designed so that they can be annealed and cloned into pX458 vector (Addgene) that was digested with Bbs I, were synthesized by Integrated DNA Technology. The pX458 vector encodes Cas9 nuclease and enhanced green fluorescent protein (EGFP) (29) . Because our preliminary experiments showed that simultaneously using two sgRNAs to target each IP 3 R was more effective in disrupting IP 3 R-encoding alleles, two sgRNAs were chosen targeting the third and fourth exons in the ITPR1 gene and the first and fourth exons in ITPR2 and ITPR3. pX458-sgRNAs were transfected into HEK293 cells. Forty-eight hours after transfection, EGFP-expressing cells were sorted and grown as single cells in 96-well plates. After 3 weeks, clones were screened by Western blotting using IP 3 R subtype-specific antibodies. Potential clones were genotyped as follows: (i) genomic DNA was isolated and amplified using a pair of primer flanking the CRISPR target site; (ii) amplicons were cloned into pcDNA3.1 (+) and sequenced; (iii) six clones were sequenced, and sequencing data indicate the introduction of indels (insertion or deletion) in both alleles. Tubes were incubated for 1 hour at 4°C with mixing every 10 min. Beads were then centrifuged at 13,000g, supernatants were removed, and 500 ml of 1% of SDS was added to each tube. After 12 to 24 hours, liquid scintillation counting was used to measure bound radioactivity. Nonspecific binding was calculated as the amount of bound radioactivity in the presence of 50 mM unlabeled IP 3 Fig. 2A) and R2R2 (Fig. 8B ).
Single-cell imaging
Cytosolic Ca 2+ changes were measured as described previously (31) . Briefly, DT40-3KO cells expressing the indicated IP 3 R constructs were loaded in imaging buffer (137 mM NaCl, 0.56 mM MgCl 2, 4.7 mM KCl, 10 mM Hepes, 5.5 mM glucose, 1.26 mM Ca
2+
, and 1 mM Na 2 HPO 4 at pH 7.4) containing 2 mM Fura2-AM and were placed on a glass coverslip mounted in a Warner chamber for 20 min at 37°C. Experiments were performed at 37°C. TILLvisION software was used for image acquisition and analyses. Experiments were repeated at least three times.
Permeabilized cell assays
Permeabilized cell assays were carried out to assess unidirectional Ca 2+ flux as described before (41) . Briefly, cells were washed once with imaging buffer and incubated with 20 mM Furaptra-AM at room temperature for 1 hour and then permeabilized using 40 mM b-escin. Intracellular Ca 
Homology modeling
A homology-based model was generated for R1 QQQ using version 9.16 of Modeller (28) in default mode. As a template, we used an available crystal structure of the IP 3 R1 N-terminal region in the absence of IP 3 (PDB ID: 3UJ4) (9). This structure is resolved to a higher resolution in this domain (3.0 Å) than the cryo-EM structure of the entire IP 3 R1 (4.7 Å), and the amino acid side chains are clearly resolved. Structural models were generated using UCSF Chimera (42) and PyMOL (Schrödinger).
Single IP 3 R1 channel measurements in isolated DT40-3KO nuclei Isolation of nuclei and on-nucleus patch clamping were described before (33) . Single IP 3 R channel potassium currents (i k ) were measured in the on-nucleus patch clamp configuration using pCLAMP 9 and an Axopatch 200B amplifier (Molecular Devices). Pipette solution contained 140 mM KCl and 10 mM Hepes, with varying concentrations of IP 3 , ATP, BAPTA, and free Ca 2+ . Free concentrations of Ca 2+ were calculated using Maxchelator freeware. Traces were consecutive 3-s sweeps recorded at −100 mV, sampled at 20 kHz, and filtered at 5 kHz. A minimum of 15 s of recordings was considered for data analyses. Pipette resistances were typically 20 megaohm and seal resistances were >5 gigaohm.
Data analysis
Single-channel openings were detected by half-threshold crossing criteria using the event detection protocol in Clampfit 9. We assumed that the number of channels in any particular cell is represented by the maximum number of discrete stacked events observed during the experiment. Even at low probability of opening (P o ), stacking events were evident. Only patches with one apparent channel were considered for analyses. P o , unitary current (i k ), open and closed times, and burst analyses were calculated using Clampfit 9 and Origin 6 software (Origin Lab). All-point current amplitude histograms were generated from the current records and fitted with a normal Gaussian probability distribution function. The coefficient of determination (R 2 ) for every fit was >0.95. The P o was calculated using the multimodal distribution for the open and closed current levels. Channel dwell-time constants for the open and closed states were determined from exponential fits of all-point histograms of open and closed times. The threshold for an open event was set at 50% of the maximum open current, and events shorter than 0.1 ms were ignored. A "burst" was defined as a period of channel opening after a period of no channel activity that was greater than five times the mean closed time within a burst. The slope conductances were determined from the linear fits of the current-voltage relationships with the equation
where g is unitary conductance, i k is unitary current, V is voltage, and V k is the reversal potential. Ca 2+ dependency curves were fitted separately for activation and inhibition with the logistic equation
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